Business Wire

BIOAUXILIUM-RESEARCH-INC

19.2.2020 15:46:13 CET | Business Wire | Press release

Share
Bioauxilium Introduces THUNDER™, a New Generation of TR‑FRET Cell Signaling Assay Kits

Bioauxilium Research Inc. , a Canadian biotech specialized in the development and manufacturing of world-class time-resolved Förster resonance energy transfer (TR‑FRET) assay kits, announced today the launch of its proprietary no-wash THUNDER TR‑FRET cellular platform with the introduction of 68 new cell signaling assay kits. These top-quality, fully validated yet affordable cell-based kinase kits were designed to enable the simple, rapid and sensitive semi-quantitative detection of specific intracellular phosphorylated and/or total proteins in cell lysates.

The ready-to-use THUNDER Cell Signaling Assay Kits are based on the higher specificity sandwich immunoassay format. However, in contrast to both conventional and improved ELISAs, they use a no-wash protocol with only one reagent addition and incubation step. This streamlined protocol dramatically decreases hands-on time and assay variability and is easily amenable to automation for high-throughput screening (HTS). The assays can be run in the same low volume using either half-area 96-well or low-volume 384-well plates.

The THUNDER assay kits combine rigorously validated antibodies, the best compatible FRET fluorophores and stringent manufacturing standards to ensure specificity, enhanced TR‑FRET assay performance and lot-to-lot consistency. All kits are subjected to a rigorous validation process using lysates from cells treated with pathway-specific activators and inhibitors, to further confirm target specificity and demonstrate performance under real assay conditions. Validation data are included in the accompanying datasheets, the most comprehensive on the market. All kits are available in several kit sizes suitable for both lab-scale experiments and high-throughput screens.

“THUNDER™ is an affordable cell-based assay platform that provides easy access to the powerful TR‑FRET technology for all researchers looking to quantify low amounts of endogenous proteins in cells,” said Jaime Padros, Ph.D., President, Bioauxilium. “We believe THUNDER™ provides for the first time a real, cost-effective alternative to ELISAs and other proprietary TR‑FRET as well as bead-based assay technologies.”

THUNDER™ kits are available worldwide and can be purchased directly through the Bioauxilium website or through one of Bioauxilium’s authorized distributors.

The THUNDER™ TR‑FRET technology is also available on request to Bioauxilium’s customers for custom antibody labelling and assay development services.

For more information on Bioauxilium and THUNDER™, visit www.bioauxilium.com .

About Bioauxilium Research Inc.
Bioauxilium is a private Canadian biotechnology company founded by expert industry scientists. It focuses on the design, development and manufacturing of top-quality, fully-validated assay kits that simplify laboratory workflow and accelerate biomedical research. Since its inception in 2013, Bioauxilium has licensed hundreds of TR‑FRET assay kits enabling the quantification of cellular proteins and biomarkers. Bioauxilium’s kits are based on its proprietary THUNDER™ TR-FRET technology. They are offered at an outstanding value and are supported by expert technical support. Bioauxilium also provides on a contract basis customized services in assay development using diverse technologies.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

HyperLight Introduces 400G-per-lane TFLN PICs on its Chiplet™ Platform for Next-Generation AI Interconnects17.3.2026 13:03:00 CET | Press release

HyperLight Corporation (“HyperLight”), creator of the TFLN Chiplet™ Platform, today announced the availability of 400G-per-lane thin-film lithium niobate (TFLN) photonic integrated circuits (PICs) designed for next-generation AI networking infrastructure. The new PIC family delivers low insertion loss, low drive voltage operation, and exceptional electro-optic bandwidth, enabling energy-efficient and high-performance 400G-per-lane optical links. The transition to 400G-per-lane is a critical step for future AI infrastructure, enabling higher interconnect bandwidth and improved system density. HyperLight’s 400G-per-lane TFLN PICs provide the large electro-optic bandwidth and low-voltage operation required to support these next-generation optical links, where bandwidth, signal integrity, and power efficiency are increasingly challenging for electronic ICs to sustain. HyperLight’s TFLN devices combine high modulation efficiency with extremely low optical loss, enabling transmitter architec

Klarna Smashes 1 Million Merchants Milestone17.3.2026 13:00:00 CET | Press release

Klarna, the global digital bank and flexible payments provider, has surpassed 1 million merchants globally. Klarna has grown the number of merchants offering its payment methods by 47% in the past year, adding 285,000 merchants in 2025, and more than 115,000 in the final quarter alone. The growth is being driven by Klarna's expanding agreements with the world's leading payment service providers, giving merchants around the world easier access to Klarna at checkout. Leisure, Sport & Hobby is now Klarna's fastest-growing merchant category, up 91% YoY in February 2026, reflecting growing consumer demand for flexible payments in wellness and fitness. David Sykes, Chief Commercial Officer at Klarna: "Home repairs, a new couch, salon appointments, gym memberships - these are facts of life for most people, but the way they pay for them hasn't kept up. Reaching 1 million merchants is a reflection of how deeply embedded Klarna is becoming in everyday money management, and the acceleration acros

Armis Warns Cyberwarfare Threats at Global Tipping Point as AI Accelerates Escalation17.3.2026 13:00:00 CET | Press release

65% of IT decision-makers believe the convergence of AI, quantum, and emerging technologies will drive unprecedented escalation in cyber conflict Half of respondents say cyberwarfare threat is imminent and have had to report an act of cyberwarfare to authorities Armis, the cyber exposure management & security company, is warning that cyberwarfare threats have reached a global pressure-cooker moment. As emerging technologies accelerate cyber operations and geopolitical tensions worsen, attackers are increasingly targeting the infrastructure, information, and systems that underpin global stability. “Geopolitical tensions, AI acceleration, and unresolved security gaps are colliding, bringing the state of cyberwarfare to a boiling point,” said Nadir Izrael, CTO and Co-Founder of Armis. “Cyberwarfare is now a constant condition; attackers are operating at machine speed, while too many organizations are still trying to defend themselves with assumptions and structures built for a very differ

1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates17.3.2026 13:00:00 CET | Press release

Fifth edition of Hologic Global Women’s Health Index reveals over half of women worldwide weren’t tested for key conditions in the past yearHologic and Gallup convene experts to discuss closing gaps in screening access Global women’s health leader Hologic, Inc. (Nasdaq: HOLX) today released data showing that while testing for some health conditions has risen among women globally, a vast screening gap remains. Over half of women and girls aged 15 and older — an estimated 1.5 billion women — were not tested for cancer, high blood pressure, diabetes or sexually transmitted infections (STIs) in the past year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260317786907/en/ Hologic Global Women's Health Index Fifth Edition The data are part of the fifth edition of the Hologic Global Women’s Health Index developed in partnership with Gallup. Based on an annual survey of 145,000 people in 144 countries and territories, the Index tra

NetApp Unveils New High-Performance EF-Series Models17.3.2026 13:00:00 CET | Press release

New systems deliver proven and affordable high-performance for most demanding workloads including AI, HPC and databases NetApp® (NASDAQ: NTAP), the Intelligent Data Infrastructure company, today announced the release of the next generation of NetApp EF-Series storage systems, built to power the most performance‑intensive workloads at scale. The introduction of EF50 and EF80 helps enterprises and neoclouds meet the growing demands of AI, high-performance computing (HPC), and transactional databases, including in emerging use cases like sovereign AI clouds and AI-powered manufacturing. “Data is the key component to delivering business value for enterprises, underpinning performance-hungry workloads like AI or databases,” said Sandeep Singh, Senior Vice President and General Manager of Enterprise Storage at NetApp. “As businesses contend with ever-increasing data volumes and performance-intensive applications such as AI model training, AI inferencing and high-performance computing, they n

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye